companydata.dkZYMENEX ApS: Financial statements 2015
CVR: 27394752
ZYMENEX ApS (CVR 27394752) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -52,501,446 and a net result of DKK 656,421 compared with DKK 1,065,781 the year before. Equity amounted to DKK -64,099,563.
- Gross Profit
- -52,501,446 kr.
- Profit/Loss
- 656,421 kr.
- Equity
- -64,099,563 kr.
- Total Assets
- 17,954,460 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | -52.5 mio. | 656 t. | -64.1 mio. | - |
| 2014 | - | -67.9 mio. | 1.1 mio. | -64.8 mio. | - |
| 2013 | - | - | -33.8 mio. | -65.8 mio. | - |
| 2012 | - | - | -42 mio. | -32.1 mio. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2015
As of November 1, 2015, Natallia Misuna has joined the board of directors of ZYMENEX ApS.
As of November 1, 2015, Claes Magnus Andersson has joined the board of directors of ZYMENEX ApS.
As of November 1, 2015, Paolo Patri has joined the board of directors of ZYMENEX ApS.
As of November 1, 2015, Danilo Piroli has left the board of directors of ZYMENEX ApS.
As of November 1, 2015, Jens Morten Fogh is registered as chairman of ZYMENEX ApS.
As of November 1, 2015, Paolo Patri is registered as director of ZYMENEX ApS.
As of November 1, 2015, Jens Morten Fogh has stepped down as direktion of ZYMENEX ApS.
As of November 1, 2015, Mark Parry-Billings has stepped down as chairman of ZYMENEX ApS.
As of October 31, 2015, Jens Morten Fogh has left the board of directors of ZYMENEX ApS.
ZYMENEX ApS has published its annual report for 2014. Gross profit came to DKK -67,882,459, and the net result was DKK 1,065,781.
About ZYMENEX ApS
ZYMENEX ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2003 and dissolved in 2019. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company has 1 employee. In 2018, the company reported revenue of DKK 10,758,000 and a net result of DKK 1,292,000 compared with DKK 3,404,000 the year before. Equity amounted to DKK 82,550,000.